<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05068934</url>
  </required_header>
  <id_info>
    <org_study_id>2020-09</org_study_id>
    <nct_id>NCT05068934</nct_id>
  </id_info>
  <brief_title>The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients</brief_title>
  <official_title>The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dongying Zhang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chongqing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart failure with preserved ejection fraction (HFpEF) refers to a group of symptoms and&#xD;
      signs of heart failure, normal or near-normal left ventricular systolic function (EF&gt;50%),&#xD;
      and ventricular muscle diastolic dysfunction and A clinical syndrome characterized by&#xD;
      decreased compliance and increased stiffness. The pathogenesis of HFpEF is related to&#xD;
      impaired lipid metabolism and inflammation. Epicardial adipose tissue (Epicardial Adipose&#xD;
      tissue, EAT) is a kind of visceral adipose tissue. Related studies have shown that&#xD;
      extracardiac Membrane fat is related to inflammation markers, cardiometabolic risk and&#xD;
      cardiovascular disease.However, there is still no research investigating the the relationship&#xD;
      between epicardial fat thickness and Cardiac Function in HFpEF patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure with preserved ejection fraction (HFpEF) refers to a group of symptoms and&#xD;
      signs of heart failure, normal or near-normal left ventricular systolic function (EF&gt;50%),&#xD;
      and ventricular muscle diastolic dysfunction and A clinical syndrome characterized by&#xD;
      decreased compliance and increased stiffness. The pathogenesis of HFpEF is related to&#xD;
      impaired lipid metabolism and inflammation. Epicardial adipose tissue (Epicardial Adipose&#xD;
      tissue, EAT) is a kind of visceral adipose tissue, which is composed of adipose tissue&#xD;
      deposited between the myocardium and the visceral layer of the pericardium. It is closely&#xD;
      adjacent to the coronary arteries and myocardium. Related studies have shown that&#xD;
      extracardiac Membrane fat is related to inflammation markers, cardiometabolic risk and&#xD;
      cardiovascular disease.However, there is still no research investigating the the relationship&#xD;
      between epicardial fat thickness and Cardiac Function in HFpEF patients. This study intends&#xD;
      to observe the relationship between epicardial fat thickness and left and right functions in&#xD;
      patients with HFpEF, and evaluate whether epicardial fat thickness can be used as an&#xD;
      indicator of left and right dysfunction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 12, 2020</start_date>
  <completion_date type="Actual">June 1, 2021</completion_date>
  <primary_completion_date type="Actual">February 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Epicardial Fat Tissue</measure>
    <time_frame>On admission</time_frame>
    <description>Epicardial Fat Tissue by cardiac color Doppler ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Function</measure>
    <time_frame>On admission</time_frame>
    <description>Left ventricular diastolic function and right ventricular systolic function by cardiac color Doppler ultrasound</description>
  </primary_outcome>
  <enrollment type="Actual">93</enrollment>
  <condition>Heart Failure With Preserved Ejection Fraction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients with preserved ejection fraction (HFpEF)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult aged &gt;=18years old;&#xD;
&#xD;
          -  Diagnosed with HFpEF.&#xD;
&#xD;
        Diagnostic criteria including:&#xD;
&#xD;
          1. left ventricular ejection fraction ≥50%；&#xD;
&#xD;
          2. with the symptoms and/or signs of heart failure；&#xD;
&#xD;
          3. BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL；&#xD;
&#xD;
          4. at least one additional criterion: relevant structural heart disease(LVH and/or LAE)&#xD;
             or diastolic dysfunction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  LVEF less than 45% at any time;&#xD;
&#xD;
          -  Severe liver failure;&#xD;
&#xD;
          -  Primary pulmonary hypertension;&#xD;
&#xD;
          -  Age &lt;18 years old.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dongying Zhang, doctor</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital of Chongqing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 26, 2021</study_first_submitted>
  <study_first_submitted_qc>September 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>September 26, 2021</last_update_submitted>
  <last_update_submitted_qc>September 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Dongying Zhang</investigator_full_name>
    <investigator_title>Dongying Zhang</investigator_title>
  </responsible_party>
  <keyword>Epicardial Adipose tissue</keyword>
  <keyword>Cardiac Function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

